Company Name: Clearside Biomedical, Inc. 

Clearside Biomedical, Inc. is a late stage clinical biopharmaceutical company. The company is engaged in the development of therapies for blinding eye diseases. The company’s developmental pipeline includes product candidates for:

  • Macular edema associated with non-infectious uveitis
  • Macular edema associated with retinal vein occlusion
  • Wet age-related macular degeneration

Ticker Symbol: CLSD (NASDAQ)

Company Website: http://clearsidebio.com

Headquarters:  Alpharetta, GA